Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora Pascual-Salcedo

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Reumatologia Clinica|June 11, 2013
Reply to: «understanding the immunogenicity concept»Alejandro Balsa, Chamaida Plasencia, Dora Pascual-Salcedo
Medicina Clinica|June 1, 2007
[Antibodies to citrullinated peptides in rheumathoid arthritis]Alejandro Balsa, Dora Pascual-Salcedo, Javier Martín
The Journal of Dermatological Treatment|March 10, 2017
Impact of immunogenicity on response to anti-TNF therapy in moderate-to-severe plaque psoriasis: results of the PREDIR studyMariano Ara-Martín, Pedro Herranz Pinto, Dora Pascual-Salcedo
Clinical Pharmacology : Advances and Applications|October 19, 2017
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseasesErwin Dreesen, Peter Bossuyt, Denis Mulleman, et al.
Rheumatology (Oxford, England)|August 9, 2014
Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experienceSara Murias, Rosa Alcobendas, Dora Pascual-Salcedo, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Medicina Clinica|May 25, 2016
[Anti-tumor necrosis factor drug therapy: The usefulness of monitoring drug levels and anti-drug antibodies in clinical practice]Jose M García Ruiz de Morales, Dora Pascual-Salcedo, Francisca Llinares Tello, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 6, 2012
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndromeAlexandru Vlagea, Antonio Gil, Maria V Cuesta, et al.
Clinical and Experimental Rheumatology|May 10, 2016
Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot studyRosa Alcobendas, Adriana Rodríguez-Vidal, Dora Pascual-Salcedo, et al.
Therapeutic Drug Monitoring|May 10, 2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory DiseasesGilles Paintaud, Christophe Passot, David Ternant, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Reumatologia Clinica|June 11, 2013
Reply to: «understanding the immunogenicity concept»Alejandro Balsa, Chamaida Plasencia, Dora Pascual-Salcedo
Medicina Clinica|June 1, 2007
[Antibodies to citrullinated peptides in rheumathoid arthritis]Alejandro Balsa, Dora Pascual-Salcedo, Javier Martín
The Journal of Dermatological Treatment|March 10, 2017
Impact of immunogenicity on response to anti-TNF therapy in moderate-to-severe plaque psoriasis: results of the PREDIR studyMariano Ara-Martín, Pedro Herranz Pinto, Dora Pascual-Salcedo
Clinical Pharmacology : Advances and Applications|October 19, 2017
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseasesErwin Dreesen, Peter Bossuyt, Denis Mulleman, et al.
Rheumatology (Oxford, England)|August 9, 2014
Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experienceSara Murias, Rosa Alcobendas, Dora Pascual-Salcedo, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Medicina Clinica|May 25, 2016
[Anti-tumor necrosis factor drug therapy: The usefulness of monitoring drug levels and anti-drug antibodies in clinical practice]Jose M García Ruiz de Morales, Dora Pascual-Salcedo, Francisca Llinares Tello, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 6, 2012
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndromeAlexandru Vlagea, Antonio Gil, Maria V Cuesta, et al.
Clinical and Experimental Rheumatology|May 10, 2016
Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot studyRosa Alcobendas, Adriana Rodríguez-Vidal, Dora Pascual-Salcedo, et al.
Therapeutic Drug Monitoring|May 10, 2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory DiseasesGilles Paintaud, Christophe Passot, David Ternant, et al.
Pageof 10